Skip to main content
OpenTrials

Clinical trial condition

Thrombocythemia, Essential

Explore clinical trials studying Thrombocythemia, Essential. Study availability and eligibility vary by location and protocol.

185 public trials 31 recruiting studies
Refine in advanced search Browse all conditions

Thrombocythemia, Essential trial results

Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NCT06661915

Conditions
Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative Neoplasm, Blood Coagulation Disorders, +19 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 31 locations
View Trial Details
Recruiting

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

NCT07623200

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Banner Md Anderson Cancer Center Gilbert, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Marin Cancer Care Greenbrae, California, United States
View all 180 locations
View Trial Details
Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

NCT07008118

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic-Florida Jacksonville, Florida, United States
View all 26 locations
View Trial Details
Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

NCT07441694

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Recruiting

A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial

NCT06786234

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Hôpital de la Milétrie, CHU Poitiers, New Aquitaine, France
  • CHU Brest Brest, France
  • Institut Paoli-Calmettes Marseille, France
  • CHU Nantes Nantes, France
View all 14 locations
View Trial Details
Recruiting

Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis

NCT07612280

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +9 more
Locations
  • St. Vincent's Hospital Sydney Limited Sydney, New South Wales, Australia
  • Macquarie University Sydney, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • St Vincent's Hospital (Melbourne) Melbourne, Victoria, Australia
View Trial Details

Related conditions